What are the major opportunities in the Androgen Deprivation Therapy market? What are the strategies for the Androgen Deprivation Therapy market?

For detailed insights on the major opportunities and strategies in the Androgen Deprivation Therapy market, Read More

How does the Androgen Deprivation Therapy market relate to the overall economy and other similar markets?

For detailed insights on Androgen Deprivation Therapy's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Androgen Deprivation Therapy market growth? SWOT analysis of the Androgen Deprivation Therapy market.

For detailed insights on the key dynamics influencing the Androgen Deprivation Therapy market growth and SWOT analysis of the Androgen Deprivation Therapy industry, Read More

Global Androgen Deprivation Therapy Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Androgen Deprivation Therapy Global Market Report 2025

Name: Androgen Deprivation Therapy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Medicine, Surgery, Other Types), By Route Of Administration (Injectable, Oral), By Patient Demographics (Men Aged 40-60, Men Aged 61-75, Men Above 75), By Application (Prostate Cancer, Other Applications), By End-User (Hospitals, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Androgen Deprivation Therapy Market Overview

• Androgen Deprivation Therapy market size has reached to $7.81 billion in 2024

• Expected to grow to $10.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%

• Growth Driver: Rising Prostate Cancer Cases Fueling The Growth Of The Market Due To Increasing Aging Population

• Market Trend: Technological Advancements In Combination Treatments For Prostate Cancer To Improve Therapeutic Efficacy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Androgen Deprivation Therapy Market?

Androgen deprivation therapy is a treatment method that reduces or suppresses the activity of male hormones in the body to limit the growth of hormone-dependent cells. These hormones play a crucial role in various physiological processes, and lowering their presence can significantly influence cellular functions and biological responses.

The main types of androgen deprivation therapy include medicine, surgery, and others. Medicine in ADT involves the use of drugs to reduce or block the production of androgens. It offers different routes of administration, including injectable and oral, and is used for various patient demographics, such as men aged 40-60, men aged 61-75, and men above 75. It is applied for prostate cancer and others by several end-users, including hospitals, specialty clinics, and others.

Androgen Deprivation Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Androgen Deprivation Therapy Market Size 2025 And Growth Rate?

The androgen deprivation therapy market size has grown strongly in recent years. It will grow from $7.81 billion in 2024 to $8.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising incidence of prostate cancer globally, increasing aging male population, high recurrence rate of prostate cancer, improved survival rates encouraging long-term treatment, and growing awareness about early prostate cancer screening.

What Is The Androgen Deprivation Therapy Market Growth Forecast?

The androgen deprivation therapy market size is expected to see strong growth in the next few years. It will grow to $10.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing adoption of combination therapies in oncology, rising prevalence of hormone-sensitive cancers, high rates of localized and advanced prostate cancer diagnosis, expanding use of ADT in non-oncological hormonal conditions, and increasing patient preference for non-invasive treatment options. Major trends in the forecast period include advancements in depot formulations and delivery methods, development of oral ADT drugs, emergence of long-acting ADT injectables, introduction of novel androgen receptor inhibitors, and technological innovations in digital pathology and diagnostics.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Androgen Deprivation Therapy Market Segmented?

1) By Type: Medicine, Surgery, Other Types

2) By Route Of Administration: Injectable, Oral

3) By Patient Demographics: Men Aged 40-60, Men Aged 61-75, Men Above 75

4) By Application: Prostate Cancer, Other Applications

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medicine: LHRH Agonists, LHRH Antagonists, Anti-Androgens, CYP17 Inhibitors, Steroidal Anti-Androgens, Non-Steroidal Anti-Androgens, Estrogen-Based Therapies, Combination Therapies

2) By Surgery: Bilateral Orchiectomy, Subcapsular Orchiectomy, Simple Orchiectomy

3) By Other Types: Radiopharmaceutical Therapy, gene therapy, Immunotherapy, targeted therapy, Cryotherapy, High-Intensity Focused Ultrasound (HIFU)

What Is Driving The Androgen Deprivation Therapy Market? Rising Prostate Cancer Cases Fueling The Growth Of The Market Due To Increasing Aging Population

The increasing incidence of prostate cancer is expected to fuel the growth of the androgen deprivation therapy market in the coming years. Prostate cancer originates in the prostate gland, a part of the male reproductive system responsible for producing seminal fluid. Its incidence is climbing mainly due to longer life spans, as older age significantly raises the risk of developing the disease. Androgen deprivation therapy (ADT) is a primary treatment modality for prostate cancer, aimed at lowering androgen levels that drive tumor growth. It is frequently utilized in advanced or metastatic stages to delay disease progression. For instance, in January 2025, according to a report published by Prostate Cancer UK, a UK-based prostate cancer research, awareness, and support organization, in England, the number of prostate cancer diagnoses increased from 50,751 cases in 2022 to 55,033 cases in 2023, indicating a clear rise in annual incidence. Therefore, the increasing incidence of prostate cancer is driving the growth of the androgen deprivation therapy industry.

Who Are The Major Players In The Global Androgen Deprivation Therapy Market?

Major companies operating in the androgen deprivation therapy market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Astellas Pharma Inc., Ipsen S.A., Dr. Reddy's Laboratories Ltd., Orion Corporation, Arvinas Inc., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Verity Pharmaceuticals Inc., Lawley Pharmaceuticals Pty Ltd.

What Are The Key Trends Of The Global Androgen Deprivation Therapy Market? Technological Advancements In Combination Treatments For Prostate Cancer To Improve Therapeutic Efficacy

Major companies operating in the androgen deprivation therapy market are focusing on developing advanced solutions, such as combination therapies, to improve treatment outcomes in advanced prostate cancer. Combination therapy involves using more than one type of treatment, such as hormone therapy plus chemotherapy, to enhance therapeutic effectiveness and delay disease progression. For instance, in August 2022, Bayer AG, a Germany-based life sciences company, received U.S. Food and Drug Administration approval for the additional indication of darolutamide in combination with docetaxel for treating metastatic hormone-sensitive prostate cancer (mHSPC). The newly approved combination therapy aims to enhance survival outcomes and delay disease advancement in individuals with metastatic hormone-sensitive prostate cancer (mHSPC), a condition where cancer has spread but still responds to hormone treatment. A standout element of this therapy is darolutamide, an oral medication that targets androgen receptors. Its unique molecular structure enables it to attach firmly to these receptors. By doing so, it effectively blocks their activity, helping to inhibit the development and spread of prostate cancer cells.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Androgen Deprivation Therapy Market? Tempus And Artera Partner To Advance Prostate Cancer Risk Assessment

In February 2025, Tempus, a US-based health technology company, partnered with Artera to bring Artera’s advanced prostate cancer risk assessment test, ArteraAI Prostate Test, to market. This collaboration aims to enhance the accuracy of cancer prognosis by using artificial intelligence to support more informed medical decisions. As a result, ArteraAI's advanced digital pathology test, included in the NCCN guidelines, will assist in identifying patients with intermediate localized prostate cancer who are more likely to benefit from short-term androgen deprivation therapy. Artera is a US-based digital health company.

What Is The Regional Outlook For The Global Androgen Deprivation Therapy Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Androgen Deprivation Therapy Industry?

The androgen deprivation therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including androgen deprivation therapy industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the androgen deprivation therapy industry. This androgen deprivation therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Androgen Deprivation Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$8.31 billion
Revenue Forecast In 2034	$10.49 billion
Growth Rate	CAGR of 6.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type, Route Of Administration, Patient Demographics, Application, End-User, Medicine, Surgery, Other Types
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Astellas Pharma Inc., Ipsen S.A., Dr. Reddy's Laboratories Ltd., Orion Corporation, Arvinas Inc., Ferring Pharmaceuticals SA, Tolmar Pharmaceuticals Inc., Besins Healthcare S.A., Veru Inc., Kintor Pharmaceutical Limited, Foresee Pharmaceuticals Co. Ltd., Verity Pharmaceuticals Inc., Lawley Pharmaceuticals Pty Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Androgen Deprivation Therapy Market Characteristics

3. Androgen Deprivation Therapy Market Trends And Strategies

4. Androgen Deprivation Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Androgen Deprivation Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Androgen Deprivation Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Androgen Deprivation Therapy Market Growth Rate Analysis

5.4. Global Androgen Deprivation Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Androgen Deprivation Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Androgen Deprivation Therapy Total Addressable Market (TAM)

6. Androgen Deprivation Therapy Market Segmentation

6.1. Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medicine

Surgery

Other Types

6.2. Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable

Oral

6.3. Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Men Aged 40-60

Men Aged 61-75

Men Above 75

6.4. Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prostate Cancer

Other Applications

6.5. Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Other End-Users

6.6. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

LHRH Agonists

LHRH Antagonists

Anti-Androgens

CYP17 Inhibitors

Steroidal Anti-Androgens

Non-Steroidal Anti-Androgens

Estrogen-Based Therapies

Combination Therapies

6.7. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bilateral Orchiectomy

Subcapsular Orchiectomy

Simple Orchiectomy

6.8. Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radiopharmaceutical Therapy

Gene Therapy

Immunotherapy

Targeted Therapy

Cryotherapy

High-Intensity Focused Ultrasound (HIFU)

7. Androgen Deprivation Therapy Market Regional And Country Analysis

7.1. Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Androgen Deprivation Therapy Market

8.1. Asia-Pacific Androgen Deprivation Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Androgen Deprivation Therapy Market

9.1. China Androgen Deprivation Therapy Market Overview

9.2. China Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Androgen Deprivation Therapy Market

10.1. India Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Androgen Deprivation Therapy Market

11.1. Japan Androgen Deprivation Therapy Market Overview

11.2. Japan Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Androgen Deprivation Therapy Market

12.1. Australia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Androgen Deprivation Therapy Market

13.1. Indonesia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Androgen Deprivation Therapy Market

14.1. South Korea Androgen Deprivation Therapy Market Overview

14.2. South Korea Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Androgen Deprivation Therapy Market

15.1. Western Europe Androgen Deprivation Therapy Market Overview

15.2. Western Europe Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Androgen Deprivation Therapy Market

16.1. UK Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Androgen Deprivation Therapy Market

17.1. Germany Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Androgen Deprivation Therapy Market

18.1. France Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Androgen Deprivation Therapy Market

19.1. Italy Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Androgen Deprivation Therapy Market

20.1. Spain Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Androgen Deprivation Therapy Market

21.1. Eastern Europe Androgen Deprivation Therapy Market Overview

21.2. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Androgen Deprivation Therapy Market

22.1. Russia Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Androgen Deprivation Therapy Market

23.1. North America Androgen Deprivation Therapy Market Overview

23.2. North America Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Androgen Deprivation Therapy Market

24.1. USA Androgen Deprivation Therapy Market Overview

24.2. USA Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Androgen Deprivation Therapy Market

25.1. Canada Androgen Deprivation Therapy Market Overview

25.2. Canada Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Androgen Deprivation Therapy Market

26.1. South America Androgen Deprivation Therapy Market Overview

26.2. South America Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Androgen Deprivation Therapy Market

27.1. Brazil Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Androgen Deprivation Therapy Market

28.1. Middle East Androgen Deprivation Therapy Market Overview

28.2. Middle East Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Androgen Deprivation Therapy Market

29.1. Africa Androgen Deprivation Therapy Market Overview

29.2. Africa Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Androgen Deprivation Therapy Market Competitive Landscape And Company Profiles

30.1. Androgen Deprivation Therapy Market Competitive Landscape

30.2. Androgen Deprivation Therapy Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Androgen Deprivation Therapy Market Other Major And Innovative Companies

31.1. AstraZeneca PLC

31.2. Novartis AG

31.3. Astellas Pharma Inc.

31.4. Ipsen S.A.

31.5. Dr. Reddy's Laboratories Ltd.

31.6. Orion Corporation

31.7. Arvinas Inc.

31.8. Ferring Pharmaceuticals SA

31.9. Tolmar Pharmaceuticals Inc.

31.10. Besins Healthcare S.A.

31.11. Veru Inc.

31.12. Kintor Pharmaceutical Limited

31.13. Foresee Pharmaceuticals Co. Ltd.

31.14. Verity Pharmaceuticals Inc.

31.15. Lawley Pharmaceuticals Pty Ltd.

32. Global Androgen Deprivation Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Androgen Deprivation Therapy Market

34. Recent Developments In The Androgen Deprivation Therapy Market

35. Androgen Deprivation Therapy Market High Potential Countries, Segments and Strategies

35.1 Androgen Deprivation Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Androgen Deprivation Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Androgen Deprivation Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: Johnson & Johnson Services Inc. Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

Table 82: Bayer AG Financial Performance

Table 83: Bristol-Myers Squibb Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Androgen Deprivation Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Androgen Deprivation Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Medicine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Androgen Deprivation Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Androgen Deprivation Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Androgen Deprivation Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Androgen Deprivation Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Androgen Deprivation Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Androgen Deprivation Therapy Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Johnson & Johnson Services Inc. Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Figure 82: Bayer AG Financial Performance

Figure 83: Bristol-Myers Squibb Company Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Testosterone Replacement Therapy Global Market Report 2025 – By Product Type (Oral, Implants, Gel Or Creams, Patches, Buccal Adhesive, Parenteral, Other Products), By Indication (Hypogonadism, Autoimmune Conditions, Gene...

Drugs For Hormonal Replacement Therapy Global Market Report 2025 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Ther...

Androgenetic Alopecia Treatment Global Market Report 2025 – By Treatment Type (Pharmaceutical, Device), By Medication Type (Prescription, Over-The-Counter), By Gender (Male, Female), By End-User (Homecare Settings, Derma...

Testosterone Booster Global Market Report 2025 – By Component (Vitamins, D-Aspartic Acid, Zinc Component), By Source (Mucuna Pruriens, Ginseng, Oyster Extract, Fenugreek), By Application (Hospitals, Retail Pharmacies) – ...

Synthetic Hormones Global Market Report 2025 – By Product Type (Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types), By Route of Administration (Oral, Nasal, Topical, Intravenous), By Applicat...

Sexual Health Supplement Global Market Report 2025 – By Type (Natural, Synthetic And Blend), By Formulation (Capsules, Tablets, Solutions, Powders, Others Formulations), By Gender (Men, Women), By Distribution (Online, O...

Hormonal Contraceptives Global Market Report 2025 – By Product (Pills, Injectable Birth Control, Vaginal Rings, Others), By End User (Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers...

Frequently Asked Questions

What is the definition of the Androgen Deprivation Therapy market?

How will the Androgen Deprivation Therapy market drivers and restraints affect the market dynamics? What forces will shape the Androgen Deprivation Therapy industry going forward?

The Androgen Deprivation Therapy market major growth driver - Rising Prostate Cancer Cases Fueling The Growth Of The Market Due To Increasing Aging Population. For further insights on the Androgen Deprivation Therapy market, request a sample here

What is the forecast market size or the forecast market value of the Androgen Deprivation Therapy market?

The Androgen Deprivation Therapy market size has grown strongly in recent years. The androgen deprivation therapy market size has grown strongly in recent years. It will grow from $7.81 billion in 2024 to $8.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising incidence of prostate cancer globally, increasing aging male population, high recurrence rate of prostate cancer, improved survival rates encouraging long-term treatment, and growing awareness about early prostate cancer screening. The androgen deprivation therapy market size is expected to see strong growth in the next few years. It will grow to $10.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing adoption of combination therapies in oncology, rising prevalence of hormone-sensitive cancers, high rates of localized and advanced prostate cancer diagnosis, expanding use of ADT in non-oncological hormonal conditions, and increasing patient preference for non-invasive treatment options. Major trends in the forecast period include advancements in depot formulations and delivery methods, development of oral ADT drugs, emergence of long-acting ADT injectables, introduction of novel androgen receptor inhibitors, and technological innovations in digital pathology and diagnostics. For further insights on the Androgen Deprivation Therapy market, request a sample here

How is the Androgen Deprivation Therapy market segmented?

The androgen deprivation therapy market covered in this report is segmented –
1) By Type: Medicine, Surgery, Other Types
2) By Route Of Administration: Injectable, Oral
3) By Patient Demographics: Men Aged 40-60, Men Aged 61-75, Men Above 75
4) By Application: Prostate Cancer, Other Applications
5) By End-User: Hospitals, Specialty Clinics, Other End-Users Subsegments:
1) By Medicine: LHRH Agonists, LHRH Antagonists, Anti-Androgens, CYP17 Inhibitors, Steroidal Anti-Androgens, Non-Steroidal Anti-Androgens, Estrogen-Based Therapies, Combination Therapies
2) By Surgery: Bilateral Orchiectomy, Subcapsular Orchiectomy, Simple Orchiectomy
3) By Other Types: Radiopharmaceutical Therapy, Gene Therapy, Immunotherapy, Targeted Therapy, Cryotherapy, High-Intensity Focused Ultrasound (HIFU For further insights on the Androgen Deprivation Therapy market, request a sample here

Which region has the largest share of the Androgen Deprivation Therapy market? What are the other regions covered in the report?

North America was the largest region in the androgen deprivation therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgen deprivation therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Androgen Deprivation Therapy market, request a sample here.

Who are the major players in the Androgen Deprivation Therapy market?

What are the key trends in the Androgen Deprivation Therapy market?

Major trends in the Androgen Deprivation Therapy market include Technological Advancements In Combination Treatments For Prostate Cancer To Improve Therapeutic Efficacy. For further insights on the Androgen Deprivation Therapy market, request a sample here.